1. Pink Sheet
  2. >>Compliance
  3. >>Manufacturing

US FDA's Program Alignment: Where Should Form-483 Responses Go After May 15?

 
• By Bowman Cox and Shawn M. Schmitt

Now that FDA is aligning its enforcement program with its product centers on May 15, there are questions about who in the agency should receive manufacturers' 15-day responses to Form-483 inspectional observations.

Pharmaceutical manufacturers will face a new challenge in responding to inspectional observations after US FDA aligns its Office of Regulatory Affairs field organization with the agency's product-oriented centers on May 15.

They won't know who should receive their responses to Form-483

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Manufacturing

More from Compliance